As of July 2025 Xencor has a market cap of ยฃ0.47 Billion. This makes Xencor the world's 6745th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Marketcap | Change |
---|---|---|
2025 | ยฃ0.47 B | -65.3% |
2024 | ยฃ1.35 B | 33.53% |
2023 | ยฃ1.01 B | -21.35% |
2022 | ยฃ1.28 B | -25.8% |
2021 | ยฃ1.73 B | -5.48% |
2020 | ยฃ1.83 B | 23.24% |
2019 | ยฃ1.49 B | -6.92% |
2018 | ยฃ1.60 B | 110.49% |
2017 | ยฃ0.76 B | -23.06% |
2016 | ยฃ0.98 B | 147.46% |
2015 | ยฃ0.40 B | 23.53% |
2014 | ยฃ0.32 B | 86.4% |
2013 | ยฃ0.17 B |
On Jul 29th, 2025 the market cap of Xencor was reported to be:
Name | Marketcap | Market cap differencediff. | Country |
---|---|---|---|
![]() Seagen
SGEN | ยฃ32.31 B | 6,774.77% | ๐บ๐ธ USA |
![]() MacroGenics MGNX | ยฃ74.64 M | -84.12% | ๐บ๐ธ USA |
![]() Amgen AMGN | ยฃ122.22 B | 25,902.73% | ๐บ๐ธ USA |
![]() Merck MRK | ยฃ155.36 B | 32,953.63% | ๐บ๐ธ USA |
![]() Johnson & Johnson JNJ | ยฃ303.16 B | 64,397.21% | ๐บ๐ธ USA |
![]() AbbVie ABBV | ยฃ252.92 B | 53,708.63% | ๐บ๐ธ USA |